The rate of adverse side effects is increased in patients with AIDS.
- TRADE NAMES: NebuPent (Astellas); Pentacarinat (Sanofi-Aventis); Pentam 300 (Astellas)
- INDICATIONS: Pneumocystis jiroveci infection, trypanosomiasis, leishmaniasis
- CLASS: Antimicrobial, Antiprotozoal
- HALF-LIFE: 9.1–13.2 hours (intramuscular); 6.5 hours (intravenous)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adefovir, Aminoglycosides, Amiodarone, Amisulpride, Amitriptyline, Amphotericin B, Cisplatin, Droperidol, Erythromycin, Foscarnet, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Ivabradine, Levomepromazine, Moxifloxacin, Phenothiazines, Saquinavir, Sparfloxacin, Sulpiride / levosulpiride, Tricyclic antidepressants, Trifluoperazine, Vancomycin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
